M. Holubová

发表

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22

B. Železná, J. Kuneš, L. Maletínská, 2021, Journal of Neuroinflammation.

Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination

M. Haluzík, B. Železná, J. Kuneš, 2018, Applied Biochemistry and Biotechnology.

Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination

M. Haluzík, B. Železná, J. Kuneš, 2016, Molecular and Cellular Endocrinology.

Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study

M. Haluzík, V. Pražienková, B. Železná, 2018, Nutrition & Diabetes.

Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.

M. Haluzík, B. Železná, J. Kuneš, 2016, The Journal of endocrinology.

Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.

D. Blum, M. Galas, V. Pražienková, 2018, Journal of Alzheimer's disease : JAD.

Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.

M. Galas, M. Haluzík, B. Železná, 2015, Journal of Alzheimer's disease : JAD.

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology

C. Hölscher, Simon Gengler, M. Haluzík, 2019, Neuropharmacology.

In vitro and in vivo characterization of novel stable peptidic ghrelin analogs: beneficial effects in the settings of LPS-induced cachexia in mice

B. Železná, J. Kuneš, L. Maletínská, 2018 .

In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice

B. Železná, J. Kuneš, L. Maletínská, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes.

M. Haluzík, B. Železná, L. Maletínská, 2014, Physiological research.

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity

M. Haluzík, V. Pražienková, B. Železná, 2017, PloS one.

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration

M. Haluzík, B. Železná, J. Kuneš, 2015, International Journal of Obesity.

Ghrelin agonists impact on Fos protein expression in brain areas related to food intake regulation in male C57BL/6 mice

J. Fehrentz, J. Bundzikova, A. Kiss, 2011, Neurochemistry International.

Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.

M. Haluzík, L. Kořínková, V. Pražienková, 2019, Journal of molecular endocrinology.

Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.

B. Železná, J. Kuneš, L. Maletínská, 2017, Journal of molecular endocrinology.

Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice.

J. Fehrentz, Z. Demianová, M. Haluzík, 2013, Physiological research.

V. Strnadová, B. Železná, J. Kuneš, 2022, Aging.

Palmitoylated prolactin-releasing peptide reduced Aβ plaques and microgliosis in the cerebellum: APP/PS1 mice study.

B. Železná, J. Kuneš, L. Maletínská, 2021, Current Alzheimer Research.

Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity

D. Novák, M. Sulc, M. Haluzík, 2015, Analytical and Bioanalytical Chemistry.

Effect of ghrelin receptor agonist and antagonist on the activity of arcuate nucleus tyrosine hydroxylase containing neurons in C57BL/6 male mice exposed to normal or high fat diet.

A. Kiss, B. Železná, L. Maletínská, 2014, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Characterization of New Stable Ghrelin Analogs with Prolonged Orexigenic Potency

Z. Demianová, B. Železná, L. Maletínská, 2012, Journal of Pharmacology and Experimental Therapeutics.

Mass spectrometry imaging of free-floating brain sections detects pathological lipid distribution in a mouse model of Alzheimer's-like pathology.

J. Cvačka, V. Vrkoslav, D. Sýkora, 2020, The Analyst.

The effects of liraglutide in mice with diet-induced obesity studied by metabolomics.

M. Haluzík, B. Železná, J. Kuneš, 2017, The Journal of endocrinology.

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22

B. Železná, J. Kuneš, L. Maletínská, 2021, Journal of Neuroinflammation.

Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.

M. Galas, V. Pražienková, B. Železná, 2019, Journal of Alzheimer's disease : JAD.

Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice

A. Moulin, J. Fehrentz, L. Maletínská, 2014, Molecular and Cellular Endocrinology.

Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.

B. Železná, J. Kuneš, L. Maletínská, 2017, Journal of molecular endocrinology.